Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 5c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.98), $0.05 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $119 million versus the consensus estimate of $132.7 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• AXT appoints Tracy Liu to its board of directors